CriPec® Nanomedicines the Translational Path from Preclinical to Clinical Studies

preview_player
Показать описание
Dr. Cristianne J. F. Rijcken, PharmD, PhD, Founder and CSO, Cristal Therapeutics, Maastricht (NL)

13. Overcoming Barriers ‐ Pharmaceutical Development and Manufacturing
CLINAM 2018
11th European and Global Summit for Clinical
Nanomedicine, Targeted Delivery and Precision Medicine
Hall Montreal
4.9.18
  1. TAUVOD
  2. CLINAM 2018
Рекомендации по теме
CriPec® Nanomedicines the 0:15:42

CriPec® Nanomedicines the Translational Path from Preclinical to Clinical Studies

CriPec Nanomedicines: Principles, 0:16:55

CriPec Nanomedicines: Principles, Preparation, Preclinical Evaluation and Early Clinical Translation

CriPec® nanomedicines: customisable 0:01:31

CriPec® nanomedicines: customisable therapeutics to bring true benefit to patients worldwide

CriPec® Platform and 0:16:45

CriPec® Platform and Lead Product CriPec® Docetaxel: Principles, Preparation, Biomedical...

Progressing the Development 0:16:07

Progressing the Development of AZD2811 Nanoparticle

Opening Address from 0:02:45

Opening Address from the European Foundation for Clinical Nanomedicine

LSX World Congress 0:09:24

LSX World Congress 2020 Presentations - Cristal Therapeutics

ondernemend apotheker Cristianne 0:02:08

ondernemend apotheker Cristianne Rijcken

CART Manufacturing 0:10:23

CART Manufacturing

Declining art of 1:24:10

Declining art of clinical medicine 200701

Gerald Bronfman Centre 0:07:03

Gerald Bronfman Centre for Clinical Research in Oncology

Is GCP Training 0:04:05

Is GCP Training Required For A Data Entry Person In A Clinical Trial?

Clinical-Anatomical Phenotypes of 0:12:15

Clinical-Anatomical Phenotypes of Schizophrenia